Redbird Research

Las Vegas, Nevada 89119

10 studies enrolling now · 14 studies all time

What they study most

Acute Migraine, Agitation, Alzheimer Disease, Bipolar I Disorder, Depression, Depressive Disorder, Major, Major Depressive Disorder, Major Depressive Disorder (MDD), Major Depressive Episode (MDE), Migraine, Schizophrenia, Social Anxiety Disorder (SAD)

Studies at this site

• A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend) — Recruiting now
• A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
• A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder — Recruiting now
• Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms — Recruiting now
• A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) — Recruiting now
• Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. — Recruiting now
• 52-week Open Label Safety-Tolerability Study — Recruiting now
• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) — Recruiting now
• A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD) — Recruiting now
• An Open-Label Study of Azetukalner in Major Depressive Disorder — Enrolling by invitation
• Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND) — Enrolling by invitation
• A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder — Completed